Is a complete CCEL research report available?

No complete published report is available for Cryo-Cell International, Inc. (CCEL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cryo-Cell International, Inc. (CCEL)

NYSEAMERICAN: CCEL · USD

$3.50

-0.04 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CCEL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	28.2M
Revenue (ttm)	31.1M
Net income (ttm)	-2.5M
EPS (ttm)	-$0.31
Shares out	8.1M
P/E (forward)	31.8x
Volume	3,462.943
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31.1M
Net income (ttm): -2.5M
EPS (ttm): -$0.31
P/E (forward): 31.8x
Market cap: 28.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CCEL indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000862692
Company name	Cryo-Cell International, Inc.
Country	United States
Country code	US
Cusip	228895108
Employees	76
Employees Change	-10%
Employees Change Percent	-11.63
Enterprise value	$33.9M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Industry PE	16.28
Industry PE Fwd	14.44
IPO Date	1997-01-21
Isin	US2288951088
Last refreshed	2026-07-24
Market cap	$28.2M
Market cap category	Nano-Cap
Price	$3.5
Price currency	USD
Rev Per Employee	409,576.68x
Sector	Healthcare
Sector PE	44.54
Sector PE Fwd	23.46
Sic	8090
Symbol	CCEL
Website	https://www.cryo-cell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.76%
EV Sales Forward	1.16x
EV/EBITDA	38.95x
EV/FCF	5.55x
EV/Sales	1.09x
FCF yield	21.71%
Forward P/E	31.82x
P/S ratio	0.9x
PS Forward	0.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.33%
EBITDA Margin	2.8%
FCF margin	19.63%
Gross margin	63.93%
Gross Profit	$19.9M
Gross Profit Growth	-18.39%
Gross Profit Growth Q	0.45%
Gross Profit Growth3 Y	-3.79%
Gross Profit Growth5 Y	0.38%
Net Income	$-2.5M
Net Income Growth Q	55.88%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-8.19%
Profit Margin	-7.92%
Profit Per Employee	$-32,452
Profitable Quarters	$2
ROA	-0.1
Roa5y	2.44
ROCE	-0.23
ROIC	-0.24
Roic5y	7.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.8%
Cagr15y	3.51%
Cagr1y	-33.86%
Cagr20y	3.48%
Cagr3y	-13.98%
Cagr5y	-14.41%
EPS Growth Q	72.11
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	2.91%
FCF Growth Q	181.29%
FCF Growth5 Y	-7.77%
OCF Growth	0.96%
OCF Growth Q	161.09%
OCF Growth10 Y	3.76%
OCF Growth3 Y	-10.31%
OCF Growth5 Y	-7.3%
Revenue Growth	-2.69x
Revenue Growth Q	-1.93x
Revenue Growth Years	0x
Revenue Growth3 Y	0.09x
Revenue Growth5 Y	0.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.5
Assets	$60.7M
Cash	$3.2M
Current Assets	$11.3M
Current Liabilities	$15.9M
Debt	$9M
Debt EBITDA	$10.28
Debt FCF	$1.47
Equity	$-17.8M
Interest Coverage	-0.05
Liabilities	$78.5M
Long Term Assets	$49.4M
Long Term Liabilities	$62.5M
Net Cash	$-5.8M
Net Cash By Market Cap	$-20.6
Net Debt EBITDA	$6.66
Net Debt FCF	$0.95
Tangible Book Value	$-20.5M
Tangible Book Value Per Share	$-2.55
WACC	9.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.71
Inventory Turnover	22.75
Net Working Capital	$-7.2M
Quick ratio	0.63
Working Capital	$-4.6M
Working Capital Turnover	$-4.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.21%
Dividend Growth Years	1%
Dividend per share	$0
Dividend Years	2
Dividend Yield	0%
Last Dividend	$0.15

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	19.55%
1Y total return	-33.84%
200-day SMA	3.66
3Y total return	-36.37%
50-day SMA	3.52
50-day SMA vs 200-day SMA	50under200
5Y total return	-54.07%
All Time High	14.16
All Time High Change	-75.28%
All Time High Date	2021-09-02
All Time Low	0.3
All Time Low Change	1,066.67%
All Time Low Date	2003-07-24
ATR	0.3
Beta	0.57
Beta1y	0.87
Beta2y	0.14
Ch YTD	1.74
High	3.62
High52	5.43
High52 Date	2025-08-06
High52ch	-35.54%
Low	3.49
Low52	2.72
Low52 Date	2026-03-25
Low52ch	28.68%
Ma50ch	-0.43%
Price vs 200-day SMA	-4.4%
RSI	50.06
RSI Monthly	37.28
RSI Weekly	48.66
Sharpe ratio	-0.18x
Sortino ratio	-0.16
Total Return	0.21%
Tr YTD	1.75
Tr15y	67.83%
Tr1m	-7.53%
Tr1w	0.57%
Tr3m	-2.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-103,776
Operating Income Growth Q	-19.78
Operating margin	-0.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,062,227%
Float Percent	50.38%
Net Borrowing	-6,780,019
Shares Insiders	40.06%
Shares Institutions	6.62%
Shares Out	8,062,650
Shares Qo Q	-0.01%
Shares Yo Y	-0.21%
Short Float	0.23%
Short Ratio	1.1
Short Shares	0.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$5.8M
Average Volume	13,776x
Bv Per Share	-2.2
CAPEX	$-205,780
Ch10y	-4.11
Ch15y	34.62
Ch1m	-7.53
Ch1w	0.57
Ch1y	-33.84
Ch20y	59.09
Ch3m	-2.23
Ch3y	-41.86
Ch5y	-63.16
Ch6m	2.34
Change	-1.13%
Change From Open	-3.31
Close	3.54
Days Gap	2.26
Depreciation Amortization	974,946
Dollar Volume	12,120.3
Earnings Date	2026-07-15
Earnings Time	amc
EBIT	$-103,776
EBITDA	$871,170
EPS	$-0.31
F Score	4
FCF	$6.1M
FCF EV Yield	18x
FCF Per Share	$0.76
Financing CF	-6,814,551
Fiscal Year End	November
Founded	1,989
Goodwill	1,941,411
Income Tax	$-81,553
Investing CF	869,095
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-15
Last Report Date	2026-05-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Ma150	3.46
Ma150ch	1.16%
Ma20	3.44
Ma20ch	1.69%
Net CF	369,811
Open	3.62
Optionable	No
P FCF Ratio	4.61
P OCF Ratio	4.46
Payment Date	2025-05-30
Position In Range	7.69
Ppne	21,290,545
Price Date	2026-07-23
Price EBITDA	$32.3
Relative Volume	0.25x
Revenue	31,127,828x
SBC By Revenue	0.97x
Share Based Comp	303,136
Tax By Revenue	-0.26x
Tr20y	98.35%
Tr6m	2.34%
Us State	Florida
Volume	3,462.9
Z Score	-0.21

Cryo-Cell International, Inc. (CCEL)

Coverage state: Market snapshot only — no published research

Generate the first CCEL analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CCEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CCEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CCEL

Frequently asked questions